
    
      Trial Features:

        -  Non-drug therapy

        -  Most patients can remain on current treatment regimen, including prednisone, budesonide
           and medications such as Asacol (mesalamine), Pentasa (mesalamine), Colazal (balsalazide
           disodium) and Dipentum (olsalazine sodium) throughout the study

      Components of the Study:

        -  Study length is 24 weeks, which includes a screening visit, ten treatment visits over
           nine weeks and 4 follow-up appointments

        -  Physical exams, laboratory tests and disease assessments conducted at no charge to the
           patient

        -  2:1 Randomization (treatment:sham)
    
  